Dynavax withdraws EU marketing application for Hep B vaccine
(Reuters) - Dynavax Technologies Corp said it had withdrawn a European marketing application for its experimental hepatitis B vaccine due to safety co...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/nGDvw2Q5CXY/story01.htm
No comments:
Post a Comment